Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study.
Saved in:
| Title: | Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study. |
|---|---|
| Authors: | Lipton, Richard B.1 (AUTHOR), Mosher, Linda2 (AUTHOR), Fountaine, Robert J.2 (AUTHOR) robert.j.fountaine@pfizer.com |
| Source: | Pain & Therapy. Feb2026, Vol. 15 Issue 1, p325-340. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
